Literature DB >> 6796778

Evidence of lack of toxicity of sodium phenylacetate and sodium benzoate in treating urea cycle enzymopathies.

M L Batshaw, S W Brusilow.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6796778     DOI： 10.1007/BF02263659

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN： 0141-8955            Impact factor:   4.982


× No keyword cloud information.
  4 in total

1.  Synthesis of phenylacetylglutamine by human tissue.

Authors:  K MOLDAVE; A MEISTER
Journal:  J Biol Chem       Date:  1957-11       Impact factor: 5.157

2.  A patient with nonketotic hyperglycinemia: biochemical findings and therapeutic approaches.

Authors:  J M Trijbels; L A Monnens; S P van der Zee; J A Vrenken; R C Sengers; E D Schretlen
Journal:  Pediatr Res       Date:  1974-05       Impact factor: 3.756

3.  Therapy of urea cycle enzymopathies: three case studies.

Authors:  M L Batshaw; M J Painter; G T Sproul; I A Schafer; G H Thomas; S Brusilow
Journal:  Johns Hopkins Med J       Date:  1981-01

4.  Inhibition by propionyl-coenzyme A of N-acetylglutamate synthetase in rat liver mitochondria. A possible explanation for hyperammonemia in propionic and methylmalonic acidemia.

Authors:  F X Coude; L Sweetman; W L Nyhan
Journal:  J Clin Invest       Date:  1979-12       Impact factor: 14.808
  4 in total
  8 in total

Review 1.  Innovative therapy for Classic Galactosemia - tale of two HTS.

Authors:  M Tang; S I Odejinmi; H Vankayalapati; K J Wierenga; K Lai
Journal:  Mol Genet Metab       Date:  2011-10-01       Impact factor: 4.797

2.  Three cases of intravenous sodium benzoate and sodium phenylacetate toxicity occurring in the treatment of acute hyperammonaemia.

Authors:  V Praphanphoj; S A Boyadjiev; L J Waber; S W Brusilow; M T Geraghty
Journal:  J Inherit Metab Dis       Date:  2000-03       Impact factor: 4.982

3.  Excretion of hippuric acid during sodium benzoate therapy in patients with hyperglycinaemia or hyperammonaemia.

Authors:  B A Barshop; J Breuer; J Holm; J Leslie; W L Nyhan
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

Review 4.  Alternative pathway therapy for urea cycle disorders.

Authors:  F Feillet; J V Leonard
Journal:  J Inherit Metab Dis       Date:  1998       Impact factor: 4.982

5.  Effect of single oral dose of sodium benzoate on ureagenesis in healthy men and two patients with late onset citrullinaemia.

Authors:  K Kubota; T Ishizaki
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 6.  The glycine deportation system and its pharmacological consequences.

Authors:  Diren Beyoğlu; Jeffrey R Idle
Journal:  Pharmacol Ther       Date:  2012-05-11       Impact factor: 12.310

7.  Cadence discovery: study protocol for a dose-finding and mechanism of action clinical trial of sodium benzoate in people with treatment-refractory schizophrenia.

Authors:  Andrea Baker; Lachlan Clarke; Peter Donovan; Jacobus P J Ungerer; Gunter Hartel; George Bruxner; Luca Cocchi; Anne Gordon; Vikas Moudgil; Gail Robinson; Digant Roy; Ravinder Sohal; Emma Whittle; James G Scott
Journal:  Trials       Date:  2021-12-13       Impact factor: 2.279

8.  The efficacy of sodium benzoate as an adjunctive treatment in early psychosis - CADENCE-BZ: study protocol for a randomized controlled trial.

Authors:  Alex Ryan; Andrea Baker; Frances Dark; Sharon Foley; Anne Gordon; Sean Hatherill; Stephen Stathis; Sukanta Saha; George Bruxner; Martin Beckman; Drew Richardson; Michael Berk; Olivia Dean; John McGrath; Cadence Working Group; James Scott
Journal:  Trials       Date:  2017-04-07       Impact factor: 2.279
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.